{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T10:07:40Z","timestamp":1699524460634},"reference-count":47,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Health, Labor and Welfare of Japan","award":["H24-Soyaku Sogo-Ippan-005"],"award-info":[{"award-number":["H24-Soyaku Sogo-Ippan-005"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.04.101","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T17:33:04Z","timestamp":1435080784000},"page":"6085-6092","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity"],"prefix":"10.1016","volume":"33","author":[{"given":"Kouki","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yamanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.04.101_bib0240","series-title":"Fields virology","first-page":"2731","article-title":"Varicella-zoster virus","author":"Arvin","year":"2001"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0245","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0250","first-page":"25","article-title":"Development of a live attenuated varicella vaccine","volume":"18","author":"Takahashi","year":"1975","journal-title":"Biken J"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2015.04.101_bib0255","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1086\/522161","article-title":"Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2015.04.101_bib0260","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0265","series-title":"Human herpesviruses: biology, therapy, and immunoprophylaxis","first-page":"1262","article-title":"Varicella-zoster vaccine","author":"Gershon","year":"2007"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0270","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/14712598.4.2.199","article-title":"Effectiveness of live varicella vaccine","volume":"4","author":"Takahashi","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0275","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1073\/pnas.84.11.3896","article-title":"Varicella-zoster virus as a live vector for the expression of foreign genes","volume":"84","author":"Lowe","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2015.04.101_bib0280","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/0022-1317-72-6-1393","article-title":"Development of immunogenic recombinant Oka varicella vaccine expressing hepatitis B virus surface antigen","volume":"72","author":"Shiraki","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0285","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jmv.1022","article-title":"Construction of Oka varicella vaccine expressing human immunodeficiency virus env antigen","volume":"64","author":"Shiraki","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0290","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.vaccine.2003.12.010","article-title":"Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge","volume":"22","author":"Heineman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0295","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1016\/j.vaccine.2004.03.062","article-title":"Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli","volume":"22","author":"Nagaike","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0300","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1016\/j.vaccine.2007.04.064","article-title":"Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus","volume":"25","author":"Yoshii","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0305","doi-asserted-by":"crossref","first-page":"8741","DOI":"10.1016\/j.vaccine.2007.10.039","article-title":"Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin\u2013neuraminidase protein as a polyvalent live vaccine","volume":"25","author":"Somboonthum","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2010.03.032","article-title":"Rapid and efficient introduction of a foreign gene into bacterial artificial chromosome-cloned varicella vaccine by Tn7-mediated site-specific transposition","volume":"402","author":"Somboonthum","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0315","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/1348-0421.12087","article-title":"Novel polyvalent live vaccine against varicella-zoster and mumps virus infections","volume":"57","author":"Matsuura","year":"2013","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0320","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0325","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1067\/mpd.2000.110531","article-title":"Rates of hospitalization for respiratory syncytial virus infection among children in medicaid","volume":"137","author":"Boyce","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0330","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002512-200522070-00004","article-title":"Respiratory syncytial virus infection in elderly adults","volume":"22","author":"Falsey","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000085367","article-title":"Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome","volume":"72","author":"Ebbert","year":"2005","journal-title":"Respiration"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0340","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0345","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0350","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/JCM.24.2.197-202.1986","article-title":"Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine","volume":"24","author":"Murphy","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0355","doi-asserted-by":"crossref","first-page":"11563","DOI":"10.1073\/pnas.92.25.11563","volume":"92","author":"Collins","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0360","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0365","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/JVI.65.3.1634-1637.1991","article-title":"Respiratory syncytial virus (RSV) F, G, M2 (22 K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived","volume":"65","author":"Connors","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0370","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1073\/pnas.83.19.7462","article-title":"Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity","volume":"83","author":"Olmsted","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0375","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JVI.60.2.607-613.1986","article-title":"Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge","volume":"60","author":"Stott","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0380","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/JVI.61.2.293-301.1987","article-title":"Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice","volume":"61","author":"Wertz","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0385","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/JVI.61.10.3163-3166.1987","article-title":"Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity","volume":"61","author":"Johnson","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0390","doi-asserted-by":"crossref","first-page":"11198","DOI":"10.1128\/JVI.78.20.11198-11207.2004","article-title":"Parainfluenza virus type 3 expressing the native or soluble fusion (F) protein of respiratory syncytial virus (RSV) confers protection from RSV infection in African green monkeys","volume":"78","author":"Tang","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0395","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.vaccine.2011.11.046","article-title":"Sendai virus-based RSV vaccine protects African green monkeys from RSV infection","volume":"30","author":"Jones","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0400","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1128\/JVI.80.3.1130-1139.2006","article-title":"Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector","volume":"80","author":"Martinez-Sobrido","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0405","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1016\/j.vaccine.2014.06.024","article-title":"Recombinant measles viruses expressing respiratory syncytial virus proteins induced virus-specific CTL responses in cotton rats","volume":"32","author":"Yamaji","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0410","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/vir.0.83453-0","article-title":"Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic","volume":"89","author":"Ward","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0415","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2010.06.016","article-title":"Characterization of varicella-zoster virus-encoded ORF0 gene\u2014comparison of parental and vaccine strains","volume":"405","author":"Koshizuka","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0420","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0425","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2144\/000112096","article-title":"Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli","volume":"40","author":"Tischer","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0430","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1073\/pnas.89.18.8794","article-title":"Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector","volume":"89","author":"Shizuya","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0435","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-60761-652-8_30","article-title":"En passant mutagenesis: a two step markerless red recombination system","volume":"634","author":"Tischer","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0440","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.virol.2008.04.039","article-title":"Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells","volume":"377","author":"Koshizuka","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0445","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/toxsci\/55.1.24","article-title":"Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations","volume":"55","author":"Driscoll","year":"2000","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0450","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1073\/pnas.90.15.7376","article-title":"Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro","volume":"90","author":"Cohen","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0455","doi-asserted-by":"crossref","first-page":"e1000971","DOI":"10.1371\/journal.ppat.1000971","article-title":"Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor","volume":"6","author":"Zhang","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0460","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1046\/j.1442-200x.2000.01300.x","article-title":"Safety and immunogenicity of live attenuated varicella vaccine in 9-month-old children","volume":"42","author":"Kanra","year":"2000","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0465","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.04.101_bib0470","doi-asserted-by":"crossref","first-page":"11447","DOI":"10.1128\/JVI.76.22.11447-11459.2002","article-title":"Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus","volume":"76","author":"Gomi","year":"2002","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T01:23:10Z","timestamp":1599182590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":47,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15006118"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.101","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}